Drospirenone is a synthetic progestin used in combination with estrogen in hormonal contraceptives. It is also used to treat moderate acne and premenstrual dysphoric disorder (PMDD). Drospirenone is known for its anti-androgenic and anti-mineralocorticoid properties, which can help in managing hormonal imbalance and associated symptoms.
Drospirenone is commonly used in combination with estrogen in oral contraceptives to prevent pregnancy. It is also prescribed for the treatment of moderate acne in females over 14 years of age who also wish to use hormonal contraception. Additionally, it is used to manage symptoms of premenstrual dysphoric disorder (PMDD) in women who are also taking hormonal contraceptives.
| Brand Name | Drospirenone |
|---|---|
| Type | |
| Weight | |
| Generic | Drospirenone |
| Manufacturer | |
| Available in | English বাংলা |
Drospirenone works by mimicking the effects of the natural hormone progesterone. It inhibits ovulation by suppressing the release of gonadotropins from the pituitary gland, which prevents the ovaries from releasing an egg. It also alters the endometrial lining, making it less suitable for implantation, and thickens cervical mucus to impede sperm passage.
When used as a contraceptive, Drospirenone , in combination with estrogen, generally provides effective pregnancy prevention after 7 days of consistent use. It may take several weeks to observe improvements in acne or PMDD symptoms.
Drospirenone is well absorbed from the gastrointestinal tract after oral administration. Its peak plasma concentrations are typically reached within 1 to 2 hours. It has high oral bioavailability, and food does not significantly affect its absorption.
Drospirenone is primarily metabolized in the liver. It is excreted in the urine as metabolites, with a small amount excreted in the feces. The drug undergoes extensive hepatic metabolism, which involves conjugation and further breakdown in the liver.
The standard dosage for Drospirenone , when used in combination with estrogen in oral contraceptives, is one tablet daily for 21 consecutive days, followed by a 7-day break or a period of inactive tablets. For the treatment of moderate acne or PMDD, the dosing regimen is similar, and the medication is generally taken continuously for 21 days, with a 7-day break or inactive tablets.
Drospirenone is administered orally in the form of tablets. For optimal effectiveness, it should be taken at the same time each day. Consistency is important to maintain effective hormone levels and prevent breakthrough bleeding or pregnancy.
Common side effects of Drospirenone include nausea, headache, breast tenderness, mood changes, and weight gain. Some users may also experience spotting or breakthrough bleeding, especially during the first few months of use.
Toxicity is rare with Drospirenone when used as directed. However, overdose can lead to severe side effects such as jaundice, severe abdominal pain, and thromboembolic events. In such cases, medical attention should be sought immediately.
Precautions should be taken in patients with a history of thromboembolic disorders, liver disease, or breast cancer. Regular monitoring is recommended for women with these conditions. Drospirenone should be used with caution in smokers over the age of 35 due to an increased risk of cardiovascular events.
Drospirenone may interact with other medications, including enzyme inducers such as rifampin and certain antiepileptics, which can reduce its effectiveness. It may also interact with medications affecting liver enzymes, potentially altering its metabolism.
In patients with renal impairment, liver disease, or a history of cardiovascular disorders, Drospirenone should be used with caution. Adjustments to dosing or alternative treatments may be necessary based on individual health conditions.
Drospirenone may interact with other medications such as antibiotics, antiepileptics, and certain HIV medications, which can impact its effectiveness. It is important to consult with a healthcare provider when taking other drugs to avoid potential interactions.
Food does not significantly affect the absorption of Drospirenone . However, it is generally recommended to take the medication with food if it causes gastrointestinal discomfort.
Drospirenone is contraindicated during pregnancy. It is classified as Category X, indicating that it has been shown to cause harm to the fetus. Women should discontinue use if pregnancy occurs or is suspected.
Drospirenone may be excreted in breast milk, but its effects on a nursing infant are not well-studied. It is advised to use alternative contraceptive methods while breastfeeding, or consult a healthcare provider for guidance on safety.
Acute overdose of Drospirenone can lead to symptoms such as severe nausea, vomiting, and abdominal discomfort. There is no specific antidote, and treatment generally involves symptomatic management and supportive care.
Drospirenone is contraindicated in individuals with known hypersensitivity to the drug or any component of the formulation, as well as in those with a history of thromboembolic disorders, liver tumors, or uncontrolled hypertension.
Drospirenone should be taken exactly as prescribed. It is important to follow the dosing schedule, take the medication consistently at the same time each day, and adhere to the recommended cycle of 21 active days followed by 7 days of inactive tablets or a break.
Drospirenone should be stored at room temperature, away from moisture and direct sunlight. Keep the medication in its original packaging to protect it from light and humidity. Do not use after the expiration date.
The volume of distribution of Drospirenone is approximately 3.5 to 4 liters/kg, indicating a moderate distribution throughout body tissues.
The elimination half-life of Drospirenone is approximately 1 to 2 days. This allows for daily dosing and consistent therapeutic levels with regular use.
Drospirenone is primarily cleared through hepatic metabolism and renal excretion. The drug's clearance is influenced by liver function, and dose adjustments may be necessary in patients with hepatic impairment.
See in details version Drospirenone also Drospirenone in bangla
Prof. Dr. Md. Golam Kibria
Gastroenterology, Liver Diseases, Pancreas & Medicine Specialist
Dr. Tanmoy Prakash Ghosh
Plastic, Burn, Hand, Breast, Aesthetic & Cosmetic Surgery Specialist